Phase II trial of induction gefitinib followed by cisplatin and docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer with EGFR activating mutation.
Phase of Trial: Phase II
Latest Information Update: 16 May 2016
At a glance
- Drugs Gefitinib (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 19 Feb 2011 New trial record